What question did this study set out to answer?

To develop a prognostic model identifying patient characteristics that predict seizure recurrence and guide decisions regarding immediate versus delayed antiepileptic drug treatment.

March 7, 2006The Lancet NeurologyOpen Access

Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial

View Full Paper

Ask AI

Bookmark

Authors

LKLois G. KimChapman University TJTony JohnsonNorthwestern University AMAnthony G MarsonNational Health Service

Discussion

Member takes

Implication

Randomized trial uncovers clinical predictors of seizure recurrence in early epilepsy, indicating that immediate treatment benefits only medium- and high-risk patients.

Key Points

To develop a prognostic model identifying patient characteristics that predict seizure recurrence and guide decisions regarding immediate versus delayed antiepileptic drug treatment.
Analyzed individual patient data from the MESS multicenter randomized trial comparing immediate with delayed antiepileptic drug therapy.
Constructed and validated a prognostic risk model using a split-sample approach to stratify patients into low, medium, and high recurrence risk groups.
Identified total seizure count at presentation, presence of a neurological disorder, and abnormal electroencephalogram (EEG) findings as significant predictors of seizure recurrence.
Categorized patients into low risk (single seizure only), medium risk (two to three seizures, neurological disorder, or abnormal EEG), and high risk (more than three seizures or at least two clinical risk factors).
Demonstrated minimal clinical benefit from immediate antiepileptic drug treatment in low-risk individuals, but worthwhile risk reductions in medium- and high-risk groups.

Cite This Study

Kim et al. (2006) studied this question.

synapsesocial.com/papers/69dbbf0550e1971baba3c646 https://doi.org/10.1016/s1474-4422(06)70383-0

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial uncovers clinical predictors of seizure recurrence in early epilepsy, indicating that immediate treatment benefits only medium- and high-risk patients.

Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider